首页 | 官方网站   微博 | 高级检索  
     

增量成本效果比在卫生技术评估中的应用
引用本文:张楠,石学峰,吴晶.增量成本效果比在卫生技术评估中的应用[J].中国卫生政策研究,2012,5(2):64-68.
作者姓名:张楠  石学峰  吴晶
作者单位:1. 天津大学药物科学与技术学院,天津,300072
2. 北京中医药大学管理学院,北京,100029
摘    要:国际上增量成本效果比在卫生技术评估中得到了广泛的应用,为卫生决策制定提供了依据。本文综述了增量成本效果比的基本概念、意义及演进过程,并以案例分析详细阐述了其在卫生决策制定中的应用,以推动卫生技术评估成为我国合理利用卫生资源、提高卫生服务效率的有效方法和手段。

关 键 词:成本效果分析  卫生技术评估  平均成本效果比  增量成本效果比  成本效果阈值
收稿时间:1/5/2012 12:00:00 AM
修稿时间:2012/1/17 0:00:00

The application of incremental cost effectiveness ratio to health technology assessment
ZHANG Nan,SHI Xue-feng,WU Jing.The application of incremental cost effectiveness ratio to health technology assessment[J].Chinese Journal of Health Policy,2012,5(2):64-68.
Authors:ZHANG Nan  SHI Xue-feng  WU Jing
Affiliation:1.School of Pharmaceutical Science and Technology,Tianjin University,Tianjin 300072,China 2.School of Management,Beijing University of Chinese Medicine,Beijing 100029,China
Abstract:Incremental cost-effectiveness ratio(ICER),as an instrument to support healthcare decision-making,has been extensively applied to Health Technology Assessment(HTA) globally.This paper has reviewed the basic concept,significance as well as evolution of ICER.A case study is also introduced to illustrate how to utilize it in real-word application.Therefore,this paper intends to provide methodological techniques and implications to promote the application of HTA in China,thereby facilitating rational use and measure of health services.
Keywords:Cost-effectiveness analysis  Health technology assessment  Average cost-effectiveness ratio  Incremental cost-effectiveness ration  Cost-effectiveness threshold
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国卫生政策研究》浏览原始摘要信息
点击此处可从《中国卫生政策研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号